Amid its various efforts to provide Covid-19 tests, Abbott Laboratories (ABT) claims to have encountered a new problem: a key employee in its diagnostics business unexpectedly resigned last month to take a job with a rival company and planned to take trade secrets with him, according to a lawsuit.
In arguing its case, Abbott maintained that Jerome Clavel, a global marketing executive who was primarily responsible for rapid diagnostic tests for infectious diseases in emerging markets, told his boss and a human resources representative that he was resigning for his health and did not have another job lined up.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author Reprints
